Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand
نویسندگان
1 Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand
2 Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand
3 Asc Academics, Groningen, The Netherlands
4 Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
5 Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
6 World Health Organization (WHO), Genève, Switzerland
7 Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand
8 World Health Organization (WHO), Genève, Switzerland
doi
10.15171/ijhpm.2020.01چکیده
BackgroundThe World Health Organization (WHO) has developed the Total System Effectiveness (TSE) framework to assist national policy-makers in prioritizing vaccines. The pilot was launched in Thailand to explore the potential use of TSE in a country with established governance structures and accountable decision-making processes for immunization policy. While the existing literature informs vaccine adoption decisions in GAVI-eligible countries, this study attempts to address a gap in the literature by examining the policy process of a non-GAVI eligible country. MethodsA rotavirus vaccine (RVV) test case was used to compare the decision criteria made by the existing processes (Expanded Program on Immunization [EPI], and National List of Essential Medicines [NLEM]) for vaccine prioritization and the TSE-pilot model, using Thailand specific data. ResultsThe existing decision-making processes in Thailand and TSE were found to offer similar recommendations on the selection of a RVV product. ConclusionThe authors believe that TSE can provide a well-reasoned and step by step approach for countries, especially low- and middle-income countries (LMICs), to develop a systematic and transparent decision-making process for immunization policy.